WTA Eligibility Policy: Addressing Recent Claims Regarding Genetic Sex Testing

Current WTA Eligibility Standards

The WTA maintains an eligibility policy designed to ensure fair competition across its professional tour. As of early 2025, the governing body continues to operate under established guidelines regarding transgender inclusion and hormone regulation. According to the [official WTA rulebook](https://www.wtatennis.com), the organization’s current policies focus on hormonal benchmarks rather than mandatory genetic screening. The existing framework allows for the participation of transgender women who meet specific, long-term testosterone suppression requirements. Specifically, athletes must demonstrate that their total serum testosterone levels have been below 2.5 nmol/L for a continuous period of at least 24 months.

Distinguishing WTA Policy from Other Sports Organizations

The confusion regarding eligibility policies stems from recent shifts in other international sporting bodies. These organizations have adopted distinct regulatory approaches that differ significantly from the current operational model of professional women’s tennis.

Why Regulatory Clarity Matters in Professional Tennis

The governance of professional sports eligibility is a complex issue involving legal, medical, and ethical considerations. The WTA has historically emphasized that its policies are subject to periodic review to balance inclusivity with competitive fairness. For fans and stakeholders, the distinction between the WTA’s existing hormone-based policy and the genetic testing models used by other sports is significant. Any updates to the WTA’s eligibility criteria are typically communicated through official channels, including the organization’s [governance portal](https://www.wtatennis.com).